Award details

Genetic recombination of traits for protective immunity and drug-resistance in the protozoan Eimeria maxima from the fowl

ReferenceBBS/E/I/00000863
Principal Investigator / Supervisor Professor Martin Shirley
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 40,120
StatusCompleted
TypeInstitute Project
Start date 01/10/2001
End date 30/09/2003
Duration24 months

Abstract

The overall objective of the work is to establish that for Eimeria maxima genetic loci encoding the phenotypes of antigenic type segregate independently of resistance to an anticoccidial drug (robenidine). This is the first part of a new strategy that aims to identify the antigens in an antigenically complex protozoan parasite that induce protective immunity during the course of natural infection. As we expect this first part of the work to be successful, we will seek further funding to map and positionally clone the genetic loci responsible. This work divides into: 1. Derivation of a series of genetic crosses between two antigenically distinct populations of E.maxima, defined also by drug-resistance or drug-sensitivity. 2. Selection of progeny in the presence of both selectable markers and confirmation by in vivo and in vitro tests that the parasites are characterised by unique recombinant phenotypes of antigenic type and drug-resistance. The successful outcome of the work will allow the derivation of clonal and non-clonal populations of recombinant parasites that can be analysed for polymorphic DNA markers to identify genetic loci that encode protective antigens. These protective antigens will provide the foundation for the development of an effective recombinant vaccine against coccidiosis.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file